HIGHLIGHTS
- who: Shixian Hu et al. from the This study included two independent Dutch cohorts: a population- representative cohort (LifeLines- DEEP) from the northern part of the Netherlands and an IBD cohort made up of patients diagnosed in the specialised IBD clinic of the University Medical Center Groningen (Groningen, the Netherlands)The LifeLines- DEEP cohort (M12.113965) was approved by the ethics committee of the University Medical Centre Groningen, with registering at the LifeLines Research Site in Groningen. All individuals were also asked to fill in the questionnaire on GI symptoms. The IBD cohort (IRB-number, .338) was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.